Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosisdoi:10.36416/1806-3756/e20220211NON-small-cell lung carcinomaCANCER patientsSPINAL cord compressionSQUAMOUS cell carcinomaCANCER relapseMartins de Bessa, CamilaMachado da Silva, Larissy...
As an inhibitor of lung cancer, EGFR-TKIs have a limited role in achieving a cure for NSCLCm+. In light of this, improving the prognosis of NSCLCm+, particularly OS, becomes a crucial focus for future research endeavors. Based on the distinct responses observed in Ex19Del and L858R NSCLC...
,... - 《Cancer Epidemiology Biomarkers & Prevention》 被引量: 32发表: 2009年 Influence of treatment and tumor grade on the prognosis of stage II carcinoma of the endometrium. A retrospective analysis of 53 patients with treated between 1963 and 1975 was undertaken to evaluate the efficacy of...
11Danish Cancer Registry, Statens Serum Institut, National Institute for Health Data and Disease Control, Copenhagen, Denmark; 12Norwegian Cancer Registry, Oslo, Norway; 13West Midlands Cancer Intelligence Unit, Birmingham, UK; 14Cancer Surveillance and Outcomes, British Columbia Cancer Agency, Vancouver...
An Overview of Stage 4 Breast Cancer Other Factors for Breast Cancer Staging To better characterize the tumor you have, other tests may be performed in addition to the TNM classification. These contribute to the prognosis and treatment approach by establishing:1 ...
Open surgery is the most common treatment for breast cancer patients. Breast cancer stage 2 is the early stage cancer and open surgery can remove the tumor and have a good prognosis. However, the worst thing is a part of the breast or the entire breast also will be removed. In Modern C...
Locally advanced breast cancer with inflammatory component: A clinical entity with a poor prognosis Radiat Oncol, 7 (1986), pp. 199-204 Google Scholar 51. S. Rouesse, D. Sarrazin, H. Mouriesse, et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230...
Gastric cancer (GC) is one of the most common malignancies and the third leading cause of cancer-related deaths worldwide1. Although diagnosis, surgical techniques, and adjuvant therapies for gastric cancer have advanced over the years, the prognosis for stage III and IV GC remains poor2. In ...
As 72% of CD45RO+ cells were also positive for CD3, the protective CD45RO+ cells in colon cancer should be predominantly CD3+ CD45RO+ memory T cells. Although a higher density of CD3+ T cells was also associated with a favorable prognosis in univariate analysis, this prognostic value ...
The median duration of response was 14 months (range, 3-55 months) for patients with bone disease and 8 months (range, 4-43 months) for those with extraskeletal lesions. We conclude that patients with metastatic breast cancer confined to the skeleton at initial diagnosis tend to follow an ...